Use of Staging Models for Treatment-Resistant Depression Is Not Helpful in Predicting Nonresponse to Acute Intravenous Ketamine Treatment

Validity of the Maudsley Staging Method in Predicting Treatment-Resistant Depression Outcome Using the Netherlands Study of Depression and Anxiety

(2018) Sjoerd M. van Belkum et al.   JOURNAL OF CLINICAL PSYCHIATRY

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder

(2018) Carola Rong et al.   International Journal of Environmental Research and Public Health

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

(2018) Maurizio Fava et al.   MOLECULAR PSYCHIATRY

A Comparison of the QIDS-C16, QIDS-SR16, and the MADRS in an Adult Outpatient Clinical Sample

(2017) Ira H. Bernstein et al.   CNS SPECTRUMS

Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation

(2016) Cristina Cusin et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Prediction of longer-term outcome of treatment-resistant depression in tertiary care

(2012) Abebaw Fekadu et al.   BRITISH JOURNAL OF PSYCHIATRY

Staging methods for treatment resistant depression. A systematic review

(2011) Henricus G. Ruhé et al.   JOURNAL OF AFFECTIVE DISORDERS

A Multidimensional Tool to Quantify Treatment Resistance in Depression

(2009) Abebaw Fekadu et al.   JOURNAL OF CLINICAL PSYCHIATRY

The Maudsley Staging Method for Treatment-Resistant Depression

(2009) Abebaw Fekadu et al.   JOURNAL OF CLINICAL PSYCHIATRY